Use and costs of anti-secretory and cardiovascular co-medication in osteoarthritis patients treated with selective or non-selective NSAIDS

Author： Simoens Steven   Coster Sandra   Ruyck Bernard   Stutz Petra   Laekeman Gert  

Publisher： Springer Publishing Company

ISSN： 0928-1231

Source： Pharmacy World and Science, Vol.28, Iss.5, 2006-10, pp. : 309-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK

By Adis International Limited  

PharmacoEconomics, Vol. 23, Iss. 7, 2005-01 ,pp. : 743-743

Adis International

Access to resources Recommend Favorite

Factors that Influence Prescribers in their Selection and use of COX-2 Selective Inhibitors as Opposed to Non-selective NSAIDs*

By Gunnarsdóttir Anna   Kinnear Moira  

Pharmacy World and Science, Vol. 27, Iss. 4, 2005-08 ,pp. : 316-320

Springer Publishing Company

Access to resources Recommend Favorite

Audit of Selective and Non‐Selective Non‐Steroidal Anti‐Inflammatory Drug Use in Rural General Practice

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 33, Iss. 1, 2003-03 ,pp. : 70-73

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gastrointestinal Effects of Selective and Non-Selective Non-Steroidal Anti- Inflammatory Drugs

By  

Current Pharmaceutical Design, Vol. 11, Iss. 14, 2005-05 ,pp. : 1779-1793

Bentham Science Publishers

Access to resources Recommend Favorite

Gastrointestinal toxicity in elderly osteoarthritis patients treated with NSAIDs

By Palmer Robert H.   DeLapp Ralph  

Inflammopharmacology, Vol. 8, Iss. 1, 2000-03 ,pp. : 19-30

VSP

Access to resources Recommend Favorite